A recent cross-sectional study compared serum vitamin D and osteocalcin...
A recent cross-sectional study compared serum vitamin D and osteocalcin levels in non-osteoporotic postmenopausal women with and without metabolic...
22 Mar, 2019
In a recent retrospective, open cohort study researchers studied the effect of glycaemic control on fracture risk in people with newly diagnosed...
15 Mar, 2019
Rheumatoid arthritis (RA) treatment generally includes conventional (cs), biologic (b) disease-modifying anti-rheumatic drugs (DMARDs) with or...
A recent observational study analyzed the relative risks (RR) of serious infections (SI) in cases with rheumatoid arthritis (RA) initiating...
08 Mar, 2019
This study determined the incidence of adverse drug reactions (ADRs) and factors associated with the safety and efficacy of adalimumab in Japanese...
ABILITY-3 study is a randomized controlled trial evaluating the safety and efficacy of continuing versus withdrawing adalimumab therapy in patients...
This is the first large contemporary analysis of real-world clinical practice that compared the risk of cardiovascular events among hip fracture...
This trial assessed the effect of intranasal salmon calcitonin in patients with fractures of spinal vertebrae. Salmon calcitonin significantly...
This datasheet covers the rationale for Risofos kit formulation, its composition, dosage and administration information.
This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...
This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.
Risendronate 150 mg is used for the management of osteoporosis. This monograph provides information on its basic pharmacology, clinical efficacy...
Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...
This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...
Majority of patients with a confirmed diagnosis of RA use nonbiologic DMARDs. The rate of biologic DMARDs use in RA treatment is also rising rapidly...
Idiopathic inflammatory myopathies (IIMs) constitute a heterogeneous group of chronic systemic autoimmune diseases with high morbidity and...